Profound Medical Analyst Price Targets - Benzinga

Profound Medical Corp

PROFNASDAQ

Trade with Public

Trade with Public

$7.00

0.456.87%

al cierre: Aug 18, 5:00 PM EST

$7.00

N/A

After hour: 4:44 PM EST

Panorámica general Noticias Previsión de beneficios EventosPrecios objetivoFinanzas Sentimiento Propiedad Comparar Opciones Informe de acciones

Profound Medical Analyst Price Targets

Wall Street analyst price targets and consensus rating for Profound Medical (PROF).

Price Target Range — 5 Quarters

Analyst Consensus — 3 Analysts

3Buy

Consensus RatingBuy# Analysts3Avg. Consensus PT$12Upside to Avg. PT+65.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jan 7, 2026	Lake Street	Benjamin Haynor	PT Raise	Buy	$11→$12
Apr 23, 2025	Lake Street	Benjamin Haynor	PT Cut	Buy	$17→$11
Jul 16, 2024	Stifel	Rick Wise	Upgrade	Hold→Buy	$9→$12
Mar 11, 2024	Alliance Global Partners	Ben Haynor	PT Cut	Buy	$13→$11
Mar 8, 2024	Stifel	Rick Wise	PT Cut	Hold	$11→$9
Jan 4, 2024	Alliance Global Partners	Ben Haynor	PT Cut	Buy	$14→$13
Nov 28, 2023	Stifel	Rick Wise	Initiate	Hold	$11

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Lake Street Maintains Buy on Profound Medical, Raises Price Target to $12

Lake Street analyst Benjamin Haynor maintains Profound Medical (NASDAQ:PROF) with a Buy and raises the price target from $11 to $12.

Benzinga Newsdesk

PRO
Lake Street Maintains Buy on Profound Medical, Lowers Price Target to $11

Lake Street analyst Benjamin Haynor maintains Profound Medical (NASDAQ:PROF) with a Buy and lowers the price target from $17 to $11.

Benzinga Newsdesk

Microsoft To Rally Around 6%? Here Are 10 Top Analyst Forecasts For Tuesday

Avi Kapoor

PRO
Stifel Upgrades Profound Medical to Buy, Raises Price Target to $12

Stifel analyst Rick Wise upgrades Profound Medical (NASDAQ:PROF) from Hold to Buy and raises the price target from $9 to $12.

Benzinga Newsdesk

PRO
Alliance Global Partners Maintains Buy on Profound Medical, Lowers Price Target to $10.8

Alliance Global Partners analyst Ben Haynor maintains Profound Medical (NASDAQ:PROF) with a Buy and lowers the price target from $12.75 to $10.8.

Benzinga Newsdesk

PRO
Stifel Maintains Hold on Profound Medical, Lowers Price Target to $9

Stifel analyst Rick Wise maintains Profound Medical (NASDAQ:PROF) with a Hold and lowers the price target from $11 to $9.

Benzinga Newsdesk